This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
New Strong Sell Stocks for January 22nd
by Zacks Equity Research
NGLOY, FMC and AG have been added to the Zacks Rank #5 (Strong Sell) List on January 22, 2023.
New Strong Sell Stocks for January 18th
by Zacks Equity Research
FMC, LANC and MCHP have been added to the Zacks Rank #5 (Strong Sell) List on January 18, 2024.
Here's Why You Should Retain FMC Corp (FMC) in Your Portfolio
by Zacks Equity Research
FMC Corp (FMC) gains on efforts to strengthen its product portfolio and price increase actions amid challenges from weaker demand due to inventory de-stocking.
FMC (FMC) Down 1.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
FMC (FMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
FMC Corp (FMC) Unveils Plan for Sustainable Profitable Growth
by Zacks Equity Research
FMC Corp (FMC) outlines its new strategic growth plan, including a focus on strengthening grower relationships, expanding the Plant Health business and accelerating R&D pipeline development.
FMC (FMC) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
FMC lags Q3 estimates amid lower sales in Latin America, channel destocking in all regions
FMC (FMC) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
FMC (FMC) delivered earnings and revenue surprises of -2.22% and 0.01%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
FMC Gears Up to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
FMC's third-quarter performance is likely to have been impacted by inventory de-stocking initiated by growers in the distribution channel in all regions.
Analysts Estimate Huntsman (HUN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Huntsman (HUN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: FMC (FMC) Q3 Earnings Expected to Decline
by Zacks Equity Research
FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMC Corp (FMC) Gains on Pricing & New Products Amid Demand Woes
by Zacks Equity Research
While FMC Corp (FMC) faces headwinds from inventory de-stocking, it benefits from its portfolio strength, new product launches and pricing actions.
FMC (FMC) Down 5.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
FMC (FMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
FMC Names Dodhylex Active as Tetflupyrolimet's Global Brand
by Zacks Equity Research
The global brand will ensure that farmers worldwide recognize this revolutionary mechanism of action in the newest herbicide products that FMC plans to offer in 2025.
FMC's Fluindapyr Fungicide Secures Registration in Brazil
by Zacks Equity Research
FMC's fluindapyr fungicide gains approval in Brazil. It offers broad-spectrum disease control for row crops.
FMC (FMC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for FMC (FMC) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
FMC's Q2 Earnings and Sales Fall Short of Expectations
by Zacks Equity Research
FMC lags second-quarter estimates due to lower volumes as a result of active inventory management by farmers.
FMC (FMC) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
FMC (FMC) delivered earnings and revenue surprises of -15.25% and 0.45%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
FMC Gears Up to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
FMC's second-quarter performance is likely to have been impacted by channel partners' inventory reduction.
Earnings Preview: FMC (FMC) Q2 Earnings Expected to Decline
by Zacks Equity Research
FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMC Shares Fall on Guidance Cut, Lower Volumes to Hurt Q2
by Zacks Equity Research
FMC revises its second-quarter and full-year 2023 outlook due to unprecedented volume declines caused by inventory reduction.
FMC (FMC) Down 10.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
FMC (FMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
FMC Partners Syngenta to Transform Rice Weed Control in Asia
by Zacks Equity Research
FMC will register and offer tetflupyrolimet as well as a variety of tetflupyrolimet formulations for rice throughout Asia.
FMC Corp's (FMC) Earnings Top Estimates in Q1, Sales Lag
by Zacks Equity Research
FMC Corp (FMC) benefits from strong pricing actions, growth of new products, expanded market access and cost discipline in Q1.
FMC (FMC) Beats Q1 Earnings Estimates
by Zacks Equity Research
FMC (FMC) delivered earnings and revenue surprises of 2.31% and 5.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Linde's (LIN) Q1 Earnings Beat Estimates on Higher Prices
by Zacks Equity Research
Increased prices and volumes across beverage and manufacturing and food end markets aid Linde's (LIN) Q1 earnings.